| COVID-19 Antibody Seroprevalence in Santa Clara County, California E Bendavid, B Mulaney, N Sood, S Shah, E Ling, R Bromley-Dulfano, ... MedRxiv, 2020 | 352 | 2020 |
| Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020 N Sood, P Simon, P Ebner, D Eichner, J Reynolds, E Bendavid, ... Jama, 2020 | 211 | 2020 |
| Immigrants and the cost of medical care DP Goldman, JP Smith, N Sood Health Affairs 25 (6), 1700-1711, 2006 | 200 | 2006 |
| Medicare spending and outcomes after post-acute care for stroke and hip fracture MB Buntin, CH Colla, P Deb, N Sood, JJ Escarce Medical care 48 (9), 776, 2010 | 187 | 2010 |
| Health cost calculator/flexible spending account calculator M Schoenbaum, M Spranca, J Bhattacharya, N Sood US Patent 7,426,474, 2008 | 177 | 2008 |
| Health insurance and the obesity externality J Bhattacharya, N Sood Advances in Health Economics and Health Services Research 17 (1), 279-318, 2006 | 176 | 2006 |
| Medicare’s bundled payment pilot for acute and postacute care: analysis and recommendations on where to begin N Sood, PJ Huckfeldt, JJ Escarce, DC Grabowski, JP Newhouse Health Affairs 30 (9), 1708-1717, 2011 | 165 | 2011 |
| Legal status and health insurance among immigrants DP Goldman, JP Smith, N Sood Health Affairs 24 (6), 1640-1653, 2005 | 164 | 2005 |
| Who pays for obesity? J Bhattacharya, N Sood Journal of Economic Perspectives 25 (1), 139-58, 2011 | 158 | 2011 |
| HIV breakthroughs and risky sexual behavior D Lakdawalla, N Sood, D Goldman The Quarterly Journal of Economics 121 (3), 1063-1102, 2006 | 158* | 2006 |
| Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development ME Blume-Kohout, N Sood Journal of public economics 97, 327-336, 2013 | 144* | 2013 |
| Healthcare spending and preventive care in high-deductible and consumer-directed health plans. MB Beeuwkes, AM Haviland, R McDevitt, N Sood The American journal of managed care 17 (3), 222-230, 2011 | 137 | 2011 |
| The link between public and private insurance and HIV-related mortality J Bhattacharya, D Goldman, N Sood Journal of health economics 22 (6), 1105-1122, 2003 | 127 | 2003 |
| The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries: If the United States implemented price controls and negotiations similar to those in … N Sood, H De Vries, I Gutierrez, DN Lakdawalla, DP Goldman Health Affairs 27 (Suppl1), w125-w137, 2008 | 122 | 2008 |
| Government health insurance for people below poverty line in India: quasi-experimental evaluation of insurance and health outcomes N Sood, E Bendavid, A Mukherji, Z Wagner, S Nagpal, P Mullen Bmj 349, g5114, 2014 | 105 | 2014 |
| Association between availability of health service prices and payments for these services C Whaley, JS Chafen, S Pinkard, G Kellerman, D Bravata, R Kocher, ... JAmA 312 (16), 1670-1676, 2014 | 95 | 2014 |
| Health infrastructure & immunization coverage in rural India A Datar, A Mukherji, N Sood Indian Journal of Medical Research 125 (1), 31, 2007 | 87 | 2007 |
| Innovation and the welfare effects of public drug insurance D Lakdawalla, N Sood Journal of public economics 93 (3-4), 541-548, 2009 | 86* | 2009 |
| University R&D funding strategies in a changing federal funding environment ME Blume-Kohout, KB Kumar, N Sood Science and Public Policy 42 (3), 355-368, 2015 | 78* | 2015 |
| Determinants of antidepressant treatment outcome N Sood, M Treglia, RL Obenchain, B Dulisse, CA Melfi, TW Croghan American Journal of Managed Care 6 (12), 1327-1339, 2000 | 74 | 2000 |
Dana P GoldmanSol Price School of Public Policy and USC School of Pharmacy, University of Southern CaliforniaVerified email at usc.edu
